A revised version of the USP chapter on Subvisible Particulate Matter USP<1788> became official on 1 st May 2021. USP<1788> is meant to expand on the information given in the chapters <787>, <788> and ...

Subvisible particulate testing is critical to assess the safety of medical devices, and particulate contamination should be minimized to avoid possible negative health consequences to the patient. A ...

Subvisible particle analysis is a key predictor of protein drug stability and a key formulation, quality metric. However, current methods use large volumes of precious protein solutions and are labor- ...

Strategies for monitoring subvisible particles in biopharmaceutical formulations are central to developing and manufacturing safe, effective drug products. This webinar will introduce flow imaging ...

In order to quantify the count and size of subvisible particles in eye care products, the USP <789> test is carried out. This consists of utilizing a light obscuration particle counter and counting ...

This educational session will focus on some of the new demands in counting particles in liquids, with a focus on the challenges of preparing and sampling protein-based materials. USP has recently ...

Editor's note: Industry Insights are sponsored blogs submitted by manufacturers and suppliers serving the fire service industry. In addition to traditional hoods, the 2018 edition of the NFPA 1971 ...

In biotherapeutic development, hitting roadblocks due to insufficient developability assessment is a common and costly setback. Traditional particle analysis methods demand more sample volume than is ...